Fourth Annual Drug Repositioning Summit
Hyatt Harborside Hotel
101 Harborside Drive
Boston, MA
 Fourth Annual Drug Repositioning Summit

 Cambridge Healthtech Institute

Schedule of Presentations:

Tuesday, October 13, 2009
07:30:00 Technologies and Novel Approaches For Drug Repositioning
08:00:00 VVP808 - Repositioning an Old Molecule as a New Insulin Sensitizer Using the Gene Expression Signature (GES)Platform Vincent Wacher
08:30:00 Phenotypic Screening with a High-Throughput in vivo Pharmacology Platform as an Effective Mode of Drug Discovery and Drug Repositioning Andrew G. Reaume
08:45:00 Using Computational Neuropharmacology to Support Repositioning Strategies in CNS Disorders Hugo Geerts
09:00:00 Intradermal Drug Delivery: A Novel Approach for Drug Repositioning Using Nanotechnology Bai Xu
09:20:00 Knowledge Management Technologies for Drug Repurposing Natalia Novac
10:00:00 Case Studies of Drug Repositioning
10:30:00 Identification of FDA-Approved Drugs with New Activity Against Leukemia Aaron D. Schimmer
10:30:00 Case Studies of Drug Repositioning in Japan
11:00:00 Drug Repositioning and Neglected Diseases
11:30:00 Drug Repositioning Programs and Models
11:30:00 Drug Repositioning and Neglected Diseases and The Johns Hopkins Clinical Compound Screening Initiative Curtis R. Chong
12:00:00 Pfizer Indications Discovery: Separating the Wheat from the Chaff Michael Barratt
Wednesday, October 14, 2009
08:00:00 Sponsored by Camargo smallBreakfast Presentation 505(b)(2): Not Just for Modifications of Approved Drugs Kenneth V. Phelps
08:30:00 Trans-National Drug Repositioning: Pursuing the Benefits of “Not Invented Here” Mondher Toumi
10:00:00 Large Scale Screening of Known Drugs for Repositioning
10:30:00 The CTSA Pharmaceutical Assets Portal Kate Marusina
11:00:00 Screening Thousands of Drugs Directly in Leukemia Patient Samples Joan Ballesteros
12:00:00 Collaborative Opportunities in Huntington’s Disease John Wityak
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.